OBJECTIVES: Oxidative stress following ischaemia and reperfusion, as well as inflammation, are thought to be important for the development of cardiac dysfunction after cardiac surgery. Our main objective was to investigate whether the inflammatory biomarkers C-reactive protein (CRP), lactoferrin, neopterin and the terminal complement complex (TCC) were associated with cardiac dysfunction after cardiac surgery. Another objective was to assess whether the biomarkers could improve prediction of postoperative cardiac dysfunction compared with clinical variables only.
INTRODUCTION
Cardiac dysfunction after heart surgery is a clinical syndrome characterized by insufficient delivery of blood to the tissues because of reduced cardiac output. A reduction in ventricular function is commonly seen following cardiac surgery, often worsening for several hours postoperatively before recovery [1] . In 5-11% of patients, the cardiac dysfunction is severe enough to require treatment with several inotropic drugs or an intra-aortic balloon pump (IABP) [2] [3] [4] , and cardiac dysfunction was the most common cause of death after coronary artery bypass grafting in a study from New England, USA [5] .
Many factors contribute to the development of cardiac dysfunction following heart surgery. Oxidative stress following ischaemia and reperfusion, and inflammation seem to be crucial [6, 7] . The inflammatory markers C-reactive protein (CRP), lactoferrin, neopterin and the terminal complement complex (TCC) have all been associated with coronary artery disease or the development of reduced ventricular function following ischaemia [8] [9] [10] . An overview of further relevant publications regarding these markers is given in Supplementary material, Table S1 . Several models for prediction of cardiac dysfunction following cardiac surgery have been published, but most of them were based on clinical variables alone [2, 4, 5] .
To explore some of the inflammatory pathways that might underlie the development of cardiac dysfunction, our main aim was to investigate whether the inflammatory biomarkers CRP, lactoferrin, neopterin and TCC were associated with cardiac dysfunction after cardiac surgery. The secondary aim was to assess whether one or several of the biomarkers could improve the accuracy of risk prediction of cardiac dysfunction after heart surgery compared with a model based on previously published clinical variables [2] .
Our hypothesis was that CRP, lactoferrin, neopterin or TCC would be associated with cardiac dysfunction after cardiac surgery, and that one or several of the biomarkers would improve the accuracy of risk prediction compared with clinical variables alone. 
MATERIALS AND METHODS

Data
In this prospective study, all adult patients undergoing cardiac surgery from 1 April 2008 to 19 April 2010 at St. Olavs University Hospital, Trondheim, Norway, were considered eligible for inclusion in the study. Patient characteristics, other diseases and risk factors, blood tests, perioperative data and data on postoperative factors and complications were collected prospectively, quality assured by a senior anaesthesiologist and stored in a local database as part of the department's quality assurance work.
We collected preoperative peripheral arterial blood samples from consecutive patients. The samples were kept on ice for a maximum of 6 h before they were centrifuged, and stored at −80°C until analysis. Of 1149 eligible patients, 21 did not consent, 32 and 7 were unable to consent due to emergency surgery and language problems, respectively, and 57 had missing blood samples. We also excluded 14 patient samples: 1 had infectious blood, 3 had active endocarditis, 2 underwent off-pump surgery, 1 did not have data on the end-point and 7 samples had an identification error preventing coupling with clinical data. Thus, 1018 patients were included in the further analyses. Patients with signs of intercurrent infection (other than endocarditis) and elevated levels of CRP were normally not considered for elective heart surgery. Data from the same cohort have been used in another publication on clinical and genetic risk factors for fluid overload following heart surgery [11] as part of CaSOS.
The end-point of the study was cardiac dysfunction after cardiac surgery, defined as the need for more than one inotropic agent or an IABP occurring after the operation and until the patient was discharged from the department. The same end-point definition was used in a previously published paper from our group [2] . Ninety-five patients (9.3%) acquired cardiac dysfunction after heart surgery according to this definition.
Biomarkers
To explore some of the underlying mechanisms of cardiac dysfunction following cardiac surgery, four biomarkers related to inflammatory pathways were analysed in plasma using enzyme immunoassay (EIA).
CRP is considered a general marker of inflammation, and is measured in all patients admitted for heart surgery. The routine method of CRP measurement used in clinical practice quantifies CRP above 5 mg/l, but quantification of CRP concentrations under 5 mg/l is also important when assessing low-grade preoperative inflammation. We therefore used a high-sensitivity method for CRP measurement using a commercial kit (Quantikine Human C-Reactive Protein Immunoassay, R&D Systems, Inc., Minneapolis, MN, USA).
Lactoferrin is considered a marker of activation of neutrophil granulocytes, and was analysed as previously described [12] . Neopterin may be seen as a marker of activated monocytes and the cellular immune system, and was analysed using a commercial kit (Neopterin ELISA, GenWay Biotech, Inc., San Diego, CA, USA). TCC, also referred to as C5b-9, is a marker of complement activation, and was analysed using a commercial kit (MicroVue SC5b-9 Plus EIA, Quidel Corporation, San Diego, CA, USA).
Statistical analysis
We used logistic regression to evaluate the association of the four biomarkers with cardiac dysfunction after cardiac surgery. We first analysed each fluid-phase marker separately (unadjusted analysis), and thereafter included the eight preoperative clinical variables found to be significant predictors of cardiac dysfunction in a previous study from our group (Table 1 ) (adjusted analysis) [2] . All four biomarkers were fitted in the same model with the clinical variables. The model was then tested for linearity in the logit, overly-influential observations and interactions, and collinearity.
Preoperative renal dysfunction was removed from the model because of strong correlation with neopterin. As sensitivity analyses, we evaluated alternative models with and without renal dysfunction and serum creatinine. Although previously not significant in our population [2] , several others have identified age and sex as important predictors of postoperative cardiac dysfunction [4, 13] , and we therefore performed a sensitivity analysis including age and sex. Neopterin and TCC were transformed by natural logarithm to fulfil the assumption of linearity in the logit. Only fluidphase markers that were significant after adjustment for clinical variables were included in further analyses.
We then tested if the significant fluid-phase marker could improve the prediction of cardiac dysfunction after heart surgery compared with clinical variables alone by performing a likelihood ratio test. Since these clinical variables were previously found to be significant in a risk prediction model for postoperative cardiac dysfunction from the same institution, we did not use backward step-down to reduce the number of predictors in the present study. Further testing of model stability and generalizability is described in the Supplementary material. We compared model discrimination by calculating the area under the receiver operating characteristic (ROC) curve (AUC) [14] , and the integrated discrimination improvement (IDI) [15] . The IDI was developed to evaluate average differences in sensitivity and specificity between models with and without new markers using average predicted probabilities, as differences in the AUC are insensitive measures of improvement in discrimination [15] .
General statistics
Descriptive statistics are given as median with 95% confidence intervals for continuous data, and frequencies with percentages for categorical data. For between-group comparisons, we used the Mann-Whitney U-test for continuous data, and Pearson's χ 2 test for categorical data. Linear correlation was assessed with Pearson's correlation coefficient. Statistical analyses were performed using the statistical software R (version 12. 
RESULTS
Patient characteristics are given in Table 2 . In the unadjusted analysis, both CRP and neopterin showed significant associations with cardiac dysfunction following cardiac surgery (Table 3 ). However, neopterin was the only significant biomarker after adjustment for urgent operation, operation type, previous cardiac surgery, chronic heart failure, pulmonary hypertension, previous myocardial infarction and preoperative haemoglobin concentration (P = 0.0005) ( Table 3, Supplementary material, Table S2 ). Neopterin was correlated with CRP (R = 0.27, P < 0.0005).
Preoperative renal dysfunction was removed from the model because of strong correlation with neopterin (R = 0.37, P < 0.0005). Neither renal dysfunction nor serum creatinine was a significant predictor of cardiac dysfunction in these patients, and the sensitivity analysis showed no difference in odds ratios after removal of renal dysfunction or creatinine from the model. As another sensitivity analysis, we also developed an alternative model including age and sex, but the odds ratios for the biomarkers were essentially unchanged (data not shown).
The likelihood ratio test showed that neopterin improved the model fit (P < 0.0001). When comparing the model containing only clinical variables with the model including neopterin as well, neopterin increased the AUC of the model from 0.817 (0.770-0.863) to 0.833 (0.779-0.874) (P = 0.07) (Fig. 1) , and the IDI was 0.014 (P = 0.02), indicating that neopterin increased discrimination. Figure 1 illustrates that neopterin increased discrimination for a group of patients in particular. These were 380 (37.3%) patients with predicted risks between 2.5 and 6.4%. This corresponded approximately to the 25th percentile, and the 60th percentile, i.e. the patients with intermediate predicted risks, having a few risk factors for cardiac dysfunction.
DISCUSSION
Preoperative neopterin levels were associated with cardiac dysfunction after cardiac surgery, also after adjustment for clinical variables. Moreover, neopterin improved the accuracy of prediction of cardiac dysfunction compared with clinical variables alone.
Cardiac dysfunction after cardiac surgery
Cardiac dysfunction following cardiopulmonary bypass is thought to result from myocardial stunning due to ischaemia and reperfusion [16] , and in part also from local and systemic inflammation [7] . It has been proposed that the mechanism involves generation of reactive oxygen species and impaired calcium homoeostasis, with damage of the sarcolemma, modification of contractile proteins and reduced calcium sensitivity [6] .
Neopterin
Neopterin is released from activated macrophages and monocytes after stimulation with interferon-γ from activated T-lymphocytes [17, 18] , and may be seen as a marker of activation of monocytes and the cellular immune system. Neopterin has been associated with left ventricular ejection fraction and cardiac dysfunction in patients with chronic stable angina pectoris [9] , and with left ventricular ejection fraction and diastolic left ventricular diameter in patients with critical limb ischaemia [19] .
Neopterin has been shown to induce contractile dysfunction in isolated perfused rat hearts [20] . Although the effective concentration in that study was higher than neopterin levels occurring in vivo, it was suggested that long-term influence of lower levels of Compared with the previously published definition, we used only three categories instead of four due to only 1 patient needing elective surgery for dissection of the ascending aorta and none undergoing surgery for rupture of the ventricular septum.
neopterin could lead to cardiac dysfunction in humans [20] . This effect could possibly be mediated through oxidative stress. A previous study has shown that neopterin enhanced the oxidative effect of hydrogen peroxide in vitro [21] . Our findings suggest that neopterin could play a role in the development of cardiac dysfunction. We measured neopterin before cardiac operation, and registered if the patient had cardiac dysfunction postoperatively. It is uncertain whether it was the specific effects of neopterin that enhanced the risk of postoperative cardiac dysfunction, if neopterin acted as a marker of inflammation in general or of activation of macrophages and the cellular immune system, or whether the association was caused by something else. However, it is possible that elevated levels of neopterin before surgery enhanced the effects of oxidative stress resulting from ischaemia and inflammation after aortic cross-clamping and cardiopulmonary bypass during heart surgery.
Other causes of elevated neopterin
Elevated levels of neopterin have been associated with acute infection, autoimmune diseases and malignancy [18] , as well as atherosclerosis [22] and left ventricular dysfunction [9] . We excluded patients with active endocarditis, and normally patients with intercurrent infections were not eligible for elective cardiac surgery until recovery. We did not have data to identify autoimmune diseases or malignancy, but the total number of affected patients is expected to be low. Atherosclerosis and left ventricular All four biomarkers in the same model, adjusted for urgent operation, operation type, previous cardiac surgery, chronic heart failure, pulmonary hypertension, previous myocardial infarction and preoperative haemoglobin concentration. b Final model adjusted for urgent operation, operation type, previous cardiac surgery, chronic heart failure, pulmonary hypertension, previous myocardial infarction and preoperative haemoglobin concentration.
c Transformed using natural logarithm. dysfunction are frequently observed in patients undergoing heart surgery, and were adjusted for.
Neopterin is biologically stable in the circulation and is eliminated by the kidneys [18] . Thus, impaired kidney function could also cause an increase in neopterin concentration. Therefore, we also analysed neopterin with adjustment for serum creatinine as well as the other clinical variables, but this did not change the results.
Improvement of risk prediction
Neopterin improved the accuracy of prediction of cardiac dysfunction after cardiac surgery. This was statistically significant according to the likelihood ratio test and the IDI, and almost significant according to the comparison of AUC for the model with and without neopterin (P = 0.07). Differences in the AUC are conservative measures of improvement in discrimination when comparing risk prediction models, yet ROC curves may be useful for describing the discrimination [15, 23] . Figure 1 indicated that neopterin improved risk prediction especially for patients with intermediate risk of postoperative cardiac dysfunction. The added value for high-risk and low-risk patients was less important. For the high-risk patients, it could be that the added effect of several risk factors overshadowed the effect of neopterin. Implementation of new biomarkers in clinical practice should rely on thorough research and evidence of its usefulness, and an evaluation of the benefit compared with the increased expenses. Presently, we therefore do not suggest that neopterin should be measured routinely before heart surgery. However, our findings support the hypothesis of the role of oxidative stress and inflammation in development of cardiac dysfunction following heart surgery.
C-reactive protein
CRP was not significant after adjustment for the clinical variables. Previous studies of the association between CRP and several cardiac end-points have shown conflicting results [8-10, 22, 24] . In our study, CRP was somewhat correlated with neopterin, and this could weaken the association between CRP and cardiac dysfunction when CRP and neopterin were analysed in the same model. Moreover, CRP is considered a more general marker of inflammation than neopterin. It is also possible that CRP represents some of the information included in the clinical variables, such as urgent operation, chronic heart failure and previous myocardial infarction, as CRP has been associated with ischaemic heart disease and chronic heart failure in previous studies [10, 24] .
CRP circulates as a pentamer, but a recent study showed that the more active monomeric form of CRP, and not the pentameric form, was found in inflamed atherosclerotic plaques and in myocardial infarction lesions in humans [25] . The different results regarding associations of CRP and cardiac end-points could be partly explained by the fact that we are measuring the circulating pentamer, which not necessarily corresponds with the concentration of monomeric, proinflammatory CRP at sites of inflammation.
As patients with signs of intercurrent infection and elevated CRP were not eligible for elective cardiac surgery, the preoperative level of CRP should reflect low-grade inflammation, and for most patients it was not expected to be measurable by routine methods used in clinical practice.
Strengths and limitations
Strengths of the present study include the large number of patients and the completeness of data, with few missing observations. However, we cannot exclude that some unknown confounders exist that we have not adjusted for. Unfortunately, we did not have complete data on left ventricular ejection fraction, and we could therefore not control for the severity of chronic heart failure. Another limitation is that the end-point definition was partly based on clinical judgement, and was therefore less specific than end-points such as mortality or myocardial infarction. The use of data from only one institution may also have introduced a bias.
CONCLUSION
Neopterin was associated with cardiac dysfunction following cardiac surgery, and improved the accuracy of risk prediction of cardiac dysfunction after heart surgery, especially in patients with intermediate risk. At present, we do not suggest that neopterin be measured routinely before heart surgery, but our findings support the hypothesis of the role of oxidative stress and inflammation in development of cardiac dysfunction following heart surgery. 
